Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
doi: 10.2147/ijn.s273713 Summary Keywords immunosuppression, immunotherapy resistance, nanomedicine delivery systems, osteosarcoma, translational oncology, tumor microenvironment (TME) Citation Huang Q, Yu G, Shi B and Deng T (2026) Engineering immunity in osteosarcoma: nanomedicine strategies for overcoming immune evasion
Doctor consultation is advised if they persist or if you're worried about them
Research has shown that MSCs modified with synthetic miRNAs can improve the sensitivity of cancer cells to chemotherapy by transferring specific miRNAs through Exos [178,179,180]
When the researchers compared the three groups, they found that the enterocytes (intestinal cells) of the non-berberine HFD group secreted significantly less GLP-1 than the healthy controls
Butanethiol has a p K a of 10.5 vs 15 for butanol
